
Sign up to save your podcasts
Or


🫀 Heart transplantation is a life-saving treatment for end-stage heart failure, but donor hearts are scarce.
🔍 Donor selection is complex, involving factors like age, heart size, LV function, and comorbidities.
🌍 The U.S. is more conservative than Europe, with higher donor heart nonuse rates.
⚙️ New tools like Predicted Heart Mass (PHM), Organ Care Systems, and AI models improve matching and outcomes.
💉 Donation after Circulatory Death (DCD) is expanding the donor pool.
⚖️ Ethical concerns and upcoming policy shifts aim for more equitable, data-driven heart allocation.
By Dr RR Baliga, MD, MBA5
66 ratings
🫀 Heart transplantation is a life-saving treatment for end-stage heart failure, but donor hearts are scarce.
🔍 Donor selection is complex, involving factors like age, heart size, LV function, and comorbidities.
🌍 The U.S. is more conservative than Europe, with higher donor heart nonuse rates.
⚙️ New tools like Predicted Heart Mass (PHM), Organ Care Systems, and AI models improve matching and outcomes.
💉 Donation after Circulatory Death (DCD) is expanding the donor pool.
⚖️ Ethical concerns and upcoming policy shifts aim for more equitable, data-driven heart allocation.

894 Listeners

3,376 Listeners

21,452 Listeners